CRNX - Crinetics Pharmaceuticals, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - CRNX (1658247)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
47 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2023-02-01
CRNXBetz Stephen F.Chief Scientific OfficerS - Sale$19.59-3,12664,689-5%-$61,238
2023-01-25
CRNXBetz Stephen F.Chief Scientific OfficerS - Sale$21.07-8,33667,815-11%-$175,640
2023-01-17
CRNXBetz Stephen F.Chief Scientific OfficerS - Sale$18.00-3,12676,151-4%-$56,268
2023-01-03
CRNXBetz Stephen F.Chief Scientific OfficerS - Sale$18.35-3,12679,277-4%-$57,362
2022-12-15
CRNXBetz Stephen F.Chief Scientific OfficerS - Sale$16.00-3,12682,403-4%-$50,016
2022-12-01
CRNXBetz Stephen F.Chief Scientific OfficerS - Sale$17.84-3,12684,968-4%-$55,768
2022-11-15
CRNXBetz Stephen F.Chief Scientific OfficerS - Sale$18.72-3,12688,094-3%-$58,519
2022-11-01
CRNXBetz Stephen F.Chief Scientific OfficerS - Sale$18.52-3,12691,220-3%-$57,894
2022-10-17
CRNXBetz Stephen F.Chief Scientific OfficerS - Sale$17.73-3,12694,346-3%-$55,424
2022-10-03
CRNXBetz Stephen F.Chief Scientific OfficerS - Sale$19.64-3,12697,472-3%-$61,395
2022-09-15
CRNXBetz Stephen F.Chief Scientific OfficerS - Sale$21.01-4,168100,598-4%-$87,570
2022-09-07
CRNXBetz Stephen F.Chief Scientific OfficerS - Sale$21.00-1,042104,766-1%-$21,884
2022-09-01
CRNXBetz Stephen F.Chief Scientific OfficerS - Sale$18.59-3,126105,808-3%-$58,112
2022-07-26
CRNXKnight Jeff E.COOS - Sale$20.70-1,1524,950-19%-$23,847
D
2022-07-13
CRNXFust Matthew KDirS - Sale+OE$20.96-5,70012,536-31%-$119,455
2022-05-02
CRNXBetz Stephen F.Chief Scientific OfficerS - Sale$20.10-3,247107,598-3%-$65,252
2022-04-18
CRNXBetz Stephen F.Chief Scientific OfficerS - Sale$25.81-5,664110,845-5%-$146,188
2022-04-18
CRNXPerceptive Advisors LLC10%P - Purchase$22.22+157,5155,321,032+3%+$3,499,983
2022-04-13
CRNXStruthers Richard ScottPres, CEOS - Sale$26.83-138,6431,059,205-12%-$3,719,625
2022-04-05
CRNXStruthers Richard ScottPres, CEOS - Sale$25.34-21,3571,197,848-2%-$541,225
2022-04-04
CRNXBetz Stephen F.Chief Scientific OfficerS - Sale$23.97-9,000116,509-7%-$215,762
M
2022-03-31
CRNXBetz Stephen F.Chief Scientific OfficerS - Sale$21.43-8,328125,509-6%-$178,475
2022-03-15
CRNXBetz Stephen F.Chief Scientific OfficerS - Sale$18.94-3,123133,837-2%-$59,150
D
2022-03-01
CRNXMadan AjayChief Development OfficerS - Sale+OE$19.88-9,000176,995-5%-$178,920
D
2022-03-01
CRNXBetz Stephen F.Chief Scientific OfficerS - Sale+OE$19.73-3,123136,960-2%-$61,617
2022-02-15
CRNXBetz Stephen F.Chief Scientific OfficerS - Sale$18.64-3,123123,583-2%-$58,213
2022-02-07
CRNXMadan AjayChief Development OfficerS - Sale$17.83-13,411172,045-7%-$239,085
2022-02-01
CRNXBetz Stephen F.Chief Scientific OfficerS - Sale$18.79-3,123126,706-2%-$58,681
D
2022-01-19
CRNXKrasner Alan SethChief Medical OfficerS - Sale+OE$21.21-6,7008,311-45%-$142,080
2022-01-18
CRNXBetz Stephen F.Chief Scientific OfficerS - Sale$23.29-4,168128,875-3%-$97,073
2022-01-03
CRNXBetz Stephen F.Chief Scientific OfficerS - Sale$28.02-7,168133,043-5%-$200,847
2021-12-28
CRNXBetz Stephen F.Chief Scientific OfficerS - Sale$27.95-3,000140,211-2%-$83,852
2021-12-15
CRNXBetz Stephen F.Chief Scientific OfficerS - Sale$24.14-5,668143,211-4%-$136,826
2021-12-01
CRNXBetz Stephen F.Chief Scientific OfficerS - Sale$27.38-5,668148,879-4%-$155,190
M
2021-11-15
CRNXBetz Stephen F.Chief Scientific OfficerS - Sale$27.01-7,168154,547-4%-$193,574
M
2021-11-05
CRNXBetz Stephen F.Chief Scientific OfficerS - Sale$28.06-16,500161,715-9%-$463,041
2021-11-01
CRNXBetz Stephen F.Chief Scientific OfficerS - Sale$24.79-5,668178,215-3%-$140,510
D
2021-11-01
CRNXFust Matthew KDirS - Sale+OE$25.50-8,95412,536-42%-$228,327
2021-10-27
CRNXBetz Stephen F.Chief Scientific OfficerS - Sale$24.00-3,000183,883-2%-$71,991
2021-10-21
CRNXBetz Stephen F.Chief Scientific OfficerS - Sale$21.10-1,042186,883-1%-$21,984
2021-10-25
CRNXPerceptive Advisors LLC10%P - Purchase$19.80+1,200,0005,163,517+30%+$23,760,000
D
2021-09-08
CRNXFust Matthew KDirS - Sale+OE$25.50-6,04612,536-33%-$154,173
2021-09-07
CRNXStruthers Richard ScottPres, CEOS - Sale$25.00-30,0001,165,805-3%-$750,000
D
2021-07-26
CRNXFust Matthew KDirS - Sale+OE$19.59-5,00012,536-29%-$97,950
D
2021-07-19
CRNXFust Matthew KDirS - Sale+OE$19.50-5,00012,536-29%-$97,500
D
2021-07-12
CRNXFust Matthew KDirS - Sale+OE$20.71-5,00012,536-29%-$103,550
2021-04-08
CRNXPerceptive Advisors LLC10%P - Purchase$16.44+304,1363,963,517+8%+$4,999,996

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top